Detailed dose evidence documented for Cerebrolysin in its monograph — reference only, not dosing recommendations.
Reference only — not a dosing recommendation.
Not established
No approved labeled regimen
No established or recommended human dose.
No single labeled regimen is summarized here because current labels and authorized indications vary by product and national regulator, and an exact current primary label was not established for every market discussed. Consult the applicable national product information; one country's label must not be transferred to another jurisdiction or indication.
Studied in trials
Studied regimens (not recommendations)
Studied in trials — not a recommended dose
The studies listed above used protocol-specific parenteral exposures under research oversight. Their dose, duration, and number of courses varied and do not establish a generally applicable regimen.
No established or recommended human dose.
Not established
What is not established
Optimal dose, duration, or interval for any indication
Comparative effectiveness against specific active therapies
Benefit in mild cognitive impairment or prevention